Paul Cardali, MD
Internal Medicine · Morristown, TNNPI 1235180159
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.8% of the total across 566 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 36 manufacturers reported payments, led by Novo Nordisk at 24.9% of the total. Reporting peaked in 2021 at $1,728 and has fallen 85.0% since, to $259 in 2025. Among internal medicine clinicians in TN with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 566 payments — averaging $15.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$2K
- GSK$1K
- AstraZeneca$1K
- Lilly USA, LLC$984
- Boehringer Ingelheim$440
- Amarin Pharma, Inc.$375
- plus $2K from 30 others
Across 4 payments — averaging $33,765 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AstraZeneca$135K
What the payments were for
- Food & beverage$8,772100%
- Education$10%
- Entertainment$130%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 144 | $2,184 |
| GSK | 97 | $1,364 |
| AstraZeneca(2 entities) | 59 | $1,143 |
| Lilly USA, LLC | 69 | $984 |
| Boehringer Ingelheim | 31 | $440 |
| Amarin Pharma, Inc. | 23 | $375 |
| Johnson & Johnson | 22 | $339 |
| Medtronic(2 entities) | 14 | $283 |
| Amgen | 19 | $263 |
| Novartis | 16 | $233 |
| AbbVie(2 entities) | 10 | $145 |
| Dexcom, Inc. | 7 | $119 |
| Xeris Pharmaceuticals, Inc. | 7 | $118 |
| Grifols USA, LLC | 6 | $108 |
| Sanofi-aventis U.S. LLC | 6 | $105 |
| Pfizer | 6 | $101 |
| Esperion Therapeutics, Inc. | 5 | $84 |
| Astellas Pharma US Inc | 3 | $39 |
| Corcept Therapeutics | 2 | $38 |
| Lifescan, Inc. | 2 | $37 |
| Abbott | 2 | $27 |
| Merck | 2 | $27 |
| Biodelivery Sciences International, Inc. | 1 | $26 |
| Kyowa Kirin, Inc. | 1 | $19 |
| Phathom Pharmaceuticals, Inc. | 1 | $19 |
| Mannkind Corporation | 1 | $19 |
| Eisai Inc. | 1 | $18 |
| Shire North American Group Inc | 1 | $17 |
| Exact Sciences | 1 | $16 |
| Arbor Pharmaceuticals, Inc. | 1 | $16 |
| Bayer | 1 | $15 |
| Paratek Pharmaceuticals, Inc. | 1 | $14 |
| Azurity Pharmaceuticals, Inc. | 1 | $14 |
| Optos, Inc. | 1 | $13 |
| E.r. Squibb & Sons, L.L.C. | 1 | $12 |
| Circassia Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,786 in reported general payments places this provider in the 90th percentile of 2,216 internal medicine providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 209 | $272,562 |
| OzempicSemaglutide | 127 | $202,394 |
| TrulicityDulaglutide | 71 | $123,980 |
| FarxigaDapagliflozin Propanediol | 96 | $100,571 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 81 | $99,485 |
| MounjaroTirzepatide | 53 | $94,471 |
| EntrestoSacubitril/Valsartan | 71 | $86,999 |
| EliquisApixaban | 81 | $75,410 |
| XareltoRivaroxaban | 61 | $61,857 |
| Tresiba Flextouch U-200Insulin Degludec | 44 | $59,448 |
| MyrbetriqMirabegron | 76 | $54,015 |
| RybelsusSemaglutide | 18 | $44,135 |
| TradjentaLinagliptin | 29 | $43,107 |
| LinzessLinaclotide | 50 | $39,581 |
| GlyxambiEmpagliflozin/Linagliptin | 27 | $36,780 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance, Tradjenta, Glyxambi, Stiolto Respimat, Synjardy Xr | $440 | $435,590358 claims |
| Novo NordiskOzempic, Rybelsus | $2,184 | $246,529145 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $984 | $218,451124 claims |
| GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta | $1,364 | $149,780139 claims |
| AstraZenecaFarxiga, Breztri Aerosphere, Symbicort | $1,143 | $138,797143 claims |
| NovartisEntresto | $233 | $86,99971 claims |
| PfizerEliquis | $101 | $75,41081 claims |
| Johnson & JohnsonXarelto | $339 | $61,85761 claims |
| Astellas Pharma US IncMyrbetriq | $39 | $54,01576 claims |
| AbbVieLinzess | $145 | $39,58150 claims |
| MerckJanuvia | $27 | $15,03819 claims |
| Esperion Therapeutics, Inc.Nexlizet | $84 | $5,39111 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,216 internal medicine providers in Tennessee.
Other internal medicine in Morristown
- John AndersonNashville$1.5M
- Tracie WalkerJackson$488K
- Nathan TrenthamEtowah$404K
- Dennis DeruelleKnoxville$263K
- Devin ShermanFranklin$191K
- Lewis HagoodKnoxville$143K
- Temidayo AbeNashville$113K
- Kenya KozawaSweetwater$86K
- Wayne RileyNashville$86K
- Maighan SeagroveChattanooga$78K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.